Literature DB >> 15931769

Regulation of cytochrome P450 by posttranslational modification.

Mike Aguiar1, Robert Masse, Bernard F Gibbs.   

Abstract

Cytochrome P450s are a family of enzymes represented in all kingdoms with expression in many species. Over 3,000 enzymes have been identified in nature. Humans express 57 putatively functional enzymes with a variety of critical physiological roles. They are involved in the metabolic oxidation, peroxidation, and reduction of many endogenous and exogenous compounds including xenobiotics, steroids, bile acids, fatty acids, eicosanoids, environmental pollutants, and carcinogens [Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O. (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12(1):1-51.] The development of numerous diseases and disorders including cancer and cardiovascular and endocrine dysfunction has been linked to P450s. Several levels of regulation, including transcription, translation, and posttranslational modification, participate in maintaining the proper function of P450s. Modifications including phosphorylation, glycosylation, nitration, and ubiquitination have been described for P450s. Their physiological significance includes modulation of enzyme activity, targeting to specific cellular compartments, and tagging for proteasomal degradation. Knowledge of P450 posttranslational regulation is derived from studies with relatively few enzymes. In many cases, there is only enough evidence to suggest the occurrence and a possible role for the modification. Thus, many P450 enzymes have not been fully characterized. With the introduction of current proteomics tools, we are primed to answer many important questions regarding regulation of P450 in response to a posttranslational modification. This review considers regulation of P450 in a context that describes the potential role and physiological significance of each modification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931769     DOI: 10.1081/dmr-46136

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  31 in total

1.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

Authors:  Xia Yang; Bin Zhang; Cliona Molony; Eugene Chudin; Ke Hao; Jun Zhu; Andrea Gaedigk; Christine Suver; Hua Zhong; J Steven Leeder; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger G Ulrich; J Greg Slatter; Eric E Schadt; Andrew Kasarskis; Pek Yee Lum
Journal:  Genome Res       Date:  2010-06-10       Impact factor: 9.043

2.  Distribution of bioactive lipid mediators in human skin.

Authors:  Alexandra C Kendall; Suzanne M Pilkington; Karen A Massey; Gary Sassano; Lesley E Rhodes; Anna Nicolaou
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

3.  Time-dependent expression and activity of cytochrome P450 1s in early life-stages of the zebrafish (Danio rerio).

Authors:  Jennifer Bräunig; Sabrina Schiwy; Oliver Broedel; Yvonne Müller; Marcus Frohme; Henner Hollert; Steffen H Keiter
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-22       Impact factor: 4.223

4.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 5.  Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Authors:  Sung-Mi Kim; YongQiang Wang; Noushin Nabavi; Yi Liu; Maria Almira Correia
Journal:  Drug Metab Rev       Date:  2016-06-20       Impact factor: 4.518

6.  Systems Biology Approaches to Enzyme Kinetics.

Authors:  Nnenna A Finn; Andrew D Raddatz; Melissa L Kemp
Journal:  Methods Mol Biol       Date:  2021

7.  Aromatase is phosphorylated in situ at serine-118.

Authors:  Todd W Miller; Incheol Shin; Norio Kagawa; Dean B Evans; Michael R Waterman; Carlos L Arteaga
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-04       Impact factor: 4.292

8.  Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration.

Authors:  Matthew E Albertolle; Thanh T N Phan; Ambra Pozzi; F Peter Guengerich
Journal:  Mol Cell Proteomics       Date:  2018-01-26       Impact factor: 5.911

9.  Fast ferrous heme-NO oxidation in nitric oxide synthases.

Authors:  Jesús Tejero; Jérôme Santolini; Dennis J Stuehr
Journal:  FEBS J       Date:  2009-08       Impact factor: 5.542

Review 10.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.